Literature DB >> 23615126

In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation?

David E Reichman1, Vinay Gunnala, Laura Meyer, Steven Spandorfer, Glenn Schattman, Owen K Davis, Zev Rosenwaks.   

Abstract

OBJECTIVE: To determine whether in vitro fertilization (IVF) cycles with suboptimal response should be converted to intrauterine insemination (IUI) or proceed to oocyte retrieval (OR).
DESIGN: Retrospective cohort.
SETTING: Academic medical center. PATIENT(S): All patients initiating IVF from January 2004 through December 2011. INTERVENTION(S): OR versus conversion to IUI. MAIN OUTCOME MEASURE(S): A total of 1,098 patients were identified whose IVF cycles were characterized by recruitment of three or fewer follicles, excluding patients with bilateral tubal disease or severe male factor. Cycles with three follicles were defined as those with three follicles ≥ 14 mm with no fourth follicle ≥ 10 mm. Cycles with two or fewer follicles were similarly defined. Outcomes were compared for patients proceeding with OR (n = 624) versus converting to IUI (n = 474). Age-adjusted relative risks for pregnancy were calculated, stratifying for number of follicles. RESULT(S): The likelihood of retrieving at least one mature oocyte (82.9% vs. 94.8% vs. 96.2%), having at least one zygote (61.9% vs. 76.8% vs. 84.2%), and undergoing transfer (57.1% vs. 73.0% vs. 83.3%) increased significantly with increasing follicle number. Patients with three or fewer follicles were 2.6 times more likely to achieve a live birth with IVF versus IUI (9.3% vs. 3.4%). This benefit was only apparent when at least two follicles were present. No benefit was gained by performing OR in the setting of one follicle. CONCLUSION(S): IVF compared with IUI presents superior pregnancy rates in the setting of two or more follicles. Assisted reproduction programs may benefit their patients by pursuing IVF in this scenario.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23615126     DOI: 10.1016/j.fertnstert.2013.02.049

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers.

Authors:  Bo Yu; Sunni Mumford; G Donald Royster; James Segars; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2014-06-18       Impact factor: 7.329

2.  The Livebirth Rate Per In Vitro Fertilization Cycle Is Higher Than The Cumulative Live Birth Rates of Intrauterine Insemination for Patients of Poseidon Group 3 With Unexplained Infertility.

Authors:  Yixuan Wu; Haiying Liu; Jianqiao Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-01       Impact factor: 5.555

3.  Influence of Maternal Age and Ovarian Reserve on the Decision to Continue or to Cancel IVF Cycles in Patients with One or Two Large Follicles: a Dual Effect.

Authors:  Guy Shrem; Mali Salmon-Divon; Alina M Mahfoudh; Jacques Balayla; Alexander Volodarsky-Perel; Sara Henderson; Atif Zeadna; Weon-Young Son; Naama Steiner; Michael H Dahan
Journal:  Reprod Sci       Date:  2021-06-11       Impact factor: 3.060

4.  ConFIRM trial - conversion of in vitro fertilization cycles to intrauterine inseminations in patients with a poor ovarian response to stimulation: a protocol for a multicentric, prospective randomized trial.

Authors:  Léa Delbos; Elsa Parot-Schinkel; Hady El Hachem; Guillaume Legendre; Philippe Descamps; Lisa Boucret; Véronique Ferré-L'Hotellier; Pauline Jeanneteau; Cécile Dreux; Catherine Morinière; Pascale May-Panloup; Pierre-Emmanuel Bouet
Journal:  Trials       Date:  2018-10-17       Impact factor: 2.279

5.  Outcomes in, and characteristics of, patients who undergo intrauterine insemination immediately after failed oocyte retrieval.

Authors:  Pietro Bortoletto; Stephanie F Willson; Phillip A Romanski; Owen K Davis; Zev Rosenwaks
Journal:  F S Rep       Date:  2020-10-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.